Detalhe da pesquisa
1.
Nkx3.1 controls the DNA repair response in the mouse prostate.
Prostate
; 76(4): 402-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26660523
2.
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.
Nat Genet
; 39(5): 645-9, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17401363
3.
Structural and functional interactions of the prostate cancer suppressor protein NKX3.1 with topoisomerase I.
Biochem J
; 453(1): 125-36, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23557481
4.
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth.
Prostate
; 72(15): 1678-87, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22473923
5.
Mortality results from a randomized prostate-cancer screening trial.
N Engl J Med
; 360(13): 1310-9, 2009 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-19297565
6.
Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer.
Cancer Med
; 11(13): 2687-2698, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293700
7.
Cross-regulation of signaling pathways: an example of nuclear hormone receptors and the canonical Wnt pathway.
Exp Cell Res
; 316(11): 1763-72, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20138864
8.
CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss.
Cancer Res
; 80(21): 4805-4814, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32943441
9.
Interactions of the acidic domain and SRF interacting motifs with the NKX3.1 homeodomain.
Biochemistry
; 48(44): 10601-7, 2009 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19780584
10.
Cumulative incidence of false-positive results in repeated, multimodal cancer screening.
Ann Fam Med
; 7(3): 212-22, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19433838
11.
Primary vulvar Ewing sarcoma/primitive neuroectodermal tumor: a report of 2 cases and review of the literature.
Int J Gynecol Cancer
; 19(6): 1131-6, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19820381
12.
NKX3.1 homeodomain protein binds to topoisomerase I and enhances its activity.
Cancer Res
; 67(2): 455-64, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17234752
13.
Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
Cancer Res
; 79(16): 4124-4134, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31213464
14.
A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.
BJU Int
; 101(9): 1084-9, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18399827
15.
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
BJU Int
; 102(11): 1524-30, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19035857
16.
Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Cancer Res
; 66(1): 69-77, 2006 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16397218
17.
Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression.
PLoS One
; 13(10): e0205837, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30321230
18.
Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
Cancer Epidemiol Biomarkers Prev
; 16(5): 962-8, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17507623
19.
Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor.
J Mol Biol
; 360(5): 989-99, 2006 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-16814806
20.
Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.
Mol Cell Biol
; 23(5): 1674-87, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12588987